Novavax
NVAX
#5737
Rank
HK$9.98 B
Marketcap
HK$60.54
Share price
-3.02%
Change (1 day)
18.37%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): -HK$11.85

According to Novavax's latest financial reports the company's current EPS (TTM) is -HK$11.92. In 2025 the company made an earnings per share (EPS) of HK$21.49 an increase over its 2024 EPS that were of -HK$9.65.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$11.85-155.16%
2025HK$21.49-322.76%
2024-HK$9.65
2022-HK$65.09-64.36%
2021-HK$182.63243%
2020-HK$53.2519.75%
2019-HK$44.46-43.86%
2018-HK$79.20-19.84%
2017-HK$98.81-38.83%
2016-HK$161.5474.58%
2015-HK$92.5363.89%
2014-HK$56.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.83-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$22.56-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-HK$20.62 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$15.84-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-HK$3.45-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$10.59-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$39.52 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA